Interestingly, circulating B cells from SLE patients show an increased level of IFN-β, especially in SLE patients with renal disease and in those with autoantibodies [104], suggesting the potential involvement of different types of IFN pathways in SLE pathogenesis. This evidence concerns the gene IFNB1 and systemic lupus erythematosus.